Skip to main content
peptidesinburleson

Peptides studied for tissue repair, tendon/ligament healing, gut mucosa, wound healing and angiogenesis.

what study titles say about the tests

What the paper titles mean

What did these papers test? Animal repair and limited human safety. Your healing remains unproved.

What title words tell you about the study

BPC-157 and TB-500: efficacy means benefit. Regeneration and regenerative mean repair; therapeutic means treatment. Musculoskeletal and orthopaedic concern muscles, bones, and joints. Systematic reviews search by rules; narrative reviews weigh selected findings.

Clinical applications mean patient care. Pro-angiogenic means growing vessels; activation switches a cell protein on. Up-regulation means making more cell protein.

Structural basis concerns shape; sequestration means holding actin, a movement protein. The actin title's code names other actin-holding proteins. Gastric means stomach; pentadecapeptide has fifteen joined protein parts.

Transected means cut through; tendocytes are tendon cells. In vitro means in dishes; intravenous infusion slowly enters a vein. Pilot means a small test; distribution means where substances spread.

Pharmacokinetics tracks blood levels; metabolism breaks substances down; excretion removes them. Dose-response compares amounts; acute means the stroke just happened. Randomized assigns people by chance; placebo-controlled includes placebo without active medicine.

  1. Mendias CL, Awan TM. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports Med. 2026. ↗
  2. et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS J. 2025. ↗
  3. et al. Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. Curr Rev Musculoskelet Med. 2025. ↗
  4. Hsieh MJ, et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. J Mol Med (Berl). 2017;95:323-333. ↗
  5. Goldstein AL, Hannappel E, Sosne G, Kleinman HK. Thymosin beta4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther. 2012. ↗
  6. Irobi E, et al. Structural basis of actin sequestration by thymosin-beta4: implications for WH2 proteins. EMBO J. 2004. ↗
  7. Staresinic M, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. J Orthop Res. 2003;21(6):976-983. ↗
  8. Lee E, Burgess K. Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study. Altern Ther Health Med. 2025. ↗
  9. He L, et al. Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs. Front Pharmacol. 2022;13:1026182. ↗
  10. Xue XC, et al. Protective effects of pentadecapeptide BPC 157 on gastric ulcer in rats. World J Gastroenterol. 2004;10:1032-1037. ↗
  11. Morris DC, et al. A dose-response study of thymosin β4 for the treatment of acute stroke. J Neurol Sci. 2014. ↗
  12. Ruff D, et al. A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin β4 in healthy volunteers. Ann N Y Acad Sci. 2010. ↗